STIM - NASDAQ
Neuronetics, Inc.
$1.39
+2.3%Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
At a Glance
Live SnapshotNeuronetics, Inc. Management Team
Mr. William P. Leonard
Chief Clinic Officer
Mr. Stephen J. Furlong M.S.
Executive Vice President, Chief Financial Officer & Treasurer
Compensation
$636,179
Mr. W. Andrew Macan J.D.
Executive Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary
Compensation
$547,313
Mr. Keith J. Sullivan
President, Chief Executive Officer & Director
Compensation
$927,610
Mr. Cory S. Anderson
SVice President & Chief Technology Officer
Ms. Lisa Metzner-Rosas
Senior Vice President & Chief Marketing Officer
Ms. Sara Grubbs
Senior Vice President & Chief Revenue Officer
Neuronetics, Inc. Insider Positioning
During the last 12 months, insiders have purchased $4.70M and sold $999K worth of STIM shares, resulting in $3.70M of net buying activity.
3 Months
3.6M
4.70M
87.3K
116.97K
+4.6M
+$4.59M
3-6 Months
0
0.00
104.9K
164.91K
-165K
-$165K
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
192.8K
717.24K
-717K
-$717K
Top Buyers
Chernett Jorey
10 Percent Owner
$4.70M
Top Sellers
Madryn Asset Management, Lp
10 Percent Owner
$717K
Sullivan Keith J
Other: Former Officer & Director
$193K
Macan William Andrew
Officer: Evp, Clo And Cs
$56K
Pfanstiel Steven
Officer: Former Evp, Cfo And Treasurer
$33K
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $3.70M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
4 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Sustained buying momentum: Consistent net buying over multiple quarters suggests insiders maintain conviction in the company's prospects. This is particularly meaningful if buying continued through market volatility.
SEC Filings
STIM - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 09, 2026 | May 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 10, 2025 | May 22, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 11, 2024 | May 30, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 13, 2023 | May 25, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 14, 2022 | May 26, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 14, 2021 | May 27, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 13, 2020 | May 26, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 12, 2019 | May 28, 2019 | 2019 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.